Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phyllis A Gimotty

Showing results (11-20 of 148) with videos related to

Pageof 15
Sort By:
Biometrics|February 12, 2008
Varying coefficient model with unknown within-subject covariance for analysis of tumor growth curvesRobert T Krafty, Phyllis A Gimotty, David Holtz, et al.
Annals of Surgical Oncology|August 12, 2020
Survival Outcomes Following Lymph Node Biopsy in Thin Melanoma-A Propensity-Matched AnalysisAndrew J Sinnamon, Phyllis A Gimotty, Giorgos C Karakousis, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|December 27, 2005
Evolution of sleep quantity, sleep deprivation, mood disturbances, empathy, and burnout among internsIlene M Rosen, Phyllis A Gimotty, Judy A Shea, et al.
Journal of Thrombosis and Thrombolysis|April 4, 2018
Quality of direct oral anticoagulant prescribing in elderly patients with non-valvular atrial fibrillation: results from a large urban health systemShakira J Grant, Shawn Kothari, Phyllis A Gimotty, et al.
Journal of Surgical Oncology|March 22, 2022
Conditional survival estimates for merkel cell carcinoma reveal the dynamic nature of prognosticationJohn T Miura, Hannah Lindner, Giorgos C Karakousis, et al.
JCO Clinical Cancer Informatics|August 1, 2024
Classification and Regression Trees to Predict for Survival for Patients With Hepatocellular Carcinoma Treated With Atezolizumab and BevacizumabTimothy J Brown, Phyllis A Gimotty, Ronac Mamtani, et al.
JB & JS Open Access|October 30, 2020
In-Hospital Complications and Readmission in Patients with Hemophilia Undergoing Hip or Knee ArthroplastyThita Chiasakul, Tyler W Buckner, Mingyang Li, et al.
Cancer|September 24, 2004
Morbidity and mortality of colorectal carcinoma surgery differs by insurance statusRachel Rapaport Kelz, Phyllis A Gimotty, Daniel Polsky, et al.
Journal of Cancer Research and Clinical Oncology|March 2, 2023
Outcomes of hepatocellular carcinoma by etiology with first-line atezolizumab and bevacizumab: a real-world analysisTimothy J Brown, Ronac Mamtani, Phyllis A Gimotty, et al.
Nature Medicine|July 26, 2016
A rapid pro-hemostatic approach to overcome direct oral anticoagulantsNabil K Thalji, Lacramioara Ivanciu, Robert Davidson, et al.
Pageof 15

Showing results (11-20 of 148) with videos related to

Sort By:
Pageof 15
Biometrics|February 12, 2008
Varying coefficient model with unknown within-subject covariance for analysis of tumor growth curvesRobert T Krafty, Phyllis A Gimotty, David Holtz, et al.
Annals of Surgical Oncology|August 12, 2020
Survival Outcomes Following Lymph Node Biopsy in Thin Melanoma-A Propensity-Matched AnalysisAndrew J Sinnamon, Phyllis A Gimotty, Giorgos C Karakousis, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|December 27, 2005
Evolution of sleep quantity, sleep deprivation, mood disturbances, empathy, and burnout among internsIlene M Rosen, Phyllis A Gimotty, Judy A Shea, et al.
Journal of Thrombosis and Thrombolysis|April 4, 2018
Quality of direct oral anticoagulant prescribing in elderly patients with non-valvular atrial fibrillation: results from a large urban health systemShakira J Grant, Shawn Kothari, Phyllis A Gimotty, et al.
Journal of Surgical Oncology|March 22, 2022
Conditional survival estimates for merkel cell carcinoma reveal the dynamic nature of prognosticationJohn T Miura, Hannah Lindner, Giorgos C Karakousis, et al.
JCO Clinical Cancer Informatics|August 1, 2024
Classification and Regression Trees to Predict for Survival for Patients With Hepatocellular Carcinoma Treated With Atezolizumab and BevacizumabTimothy J Brown, Phyllis A Gimotty, Ronac Mamtani, et al.
JB & JS Open Access|October 30, 2020
In-Hospital Complications and Readmission in Patients with Hemophilia Undergoing Hip or Knee ArthroplastyThita Chiasakul, Tyler W Buckner, Mingyang Li, et al.
Cancer|September 24, 2004
Morbidity and mortality of colorectal carcinoma surgery differs by insurance statusRachel Rapaport Kelz, Phyllis A Gimotty, Daniel Polsky, et al.
Journal of Cancer Research and Clinical Oncology|March 2, 2023
Outcomes of hepatocellular carcinoma by etiology with first-line atezolizumab and bevacizumab: a real-world analysisTimothy J Brown, Ronac Mamtani, Phyllis A Gimotty, et al.
Nature Medicine|July 26, 2016
A rapid pro-hemostatic approach to overcome direct oral anticoagulantsNabil K Thalji, Lacramioara Ivanciu, Robert Davidson, et al.
Pageof 15